Commentary
The study by KWM Abeysekera et al. (Population Health Sciences, Bristol Medical School, University of Bristol, and University Hospitals Bristol NHS Foundation Trust, Bristol, UK) is the first to determine the prevalence of NAFLD in young adults with use of transient electrography, in an age group in which NAFLD burden is poorly characterized.
The group of young adults from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort has already been assessed for NAFLD between the ages of 17 and 18 years, which acts as a comparator.
The authors identified that around 20% of young adults had steatosis of grade S1 or higher around the age of 24 years. One in 40 also had evidence of liver fibrosis.
